title: [Natural history and management of retroperitoneal sarcoma: Review of the literature by the Oncology committee of the French association of urology].
abstract: BACKGROUND
  The objective of this article of review is to precise the natural history and rules of treatment of retroperitoneal sarcoma. These elements are sometimes ignored of the urologists.
  
  
  METHODS
  A systematic review of the literature over the 15 last years was carried out on Medline database.
  
  
  RESULTS
  The sarcomas of the rétropéritoine are found with diagnosis delay because they don't have specific symptoms. The imagery is sometimes characteristic but only percutaneous biopsy is able to confirm the diagnosis. Retroperitoneal sarcomas are characterized by the high rate of local recurrence, which is related to the survival rate. The main prognostic factors are negative margins and grade of the tumor. The role of adjuvant radiotherapy is limited by the radio sensitivity of the abdominal viscera and the postoperative rehandlings. Today, the role of the neoadjuvant radiotherapy is in evaluation in prospective study. The effectiveness of chemotherapy is limited.
  
  
  CONCLUSIONS
  Complete compartmental surgery without tumor rupture is the cornerstone of treatment. This complex surgery should be performed in a high-volume center.
authors.affiliation: Service d'urologie, clinique kenVal, 30000 Nîmes, France. christophe.avances@free.fr
authors.forename: C
authors.initials: C
authors.lastname: Avancès
authors.forename: P
authors.initials: P
authors.lastname: Camparo
authors.forename: F
authors.initials: F
authors.lastname: Quenet
authors.forename: X
authors.initials: X
authors.lastname: Durand
authors.forename: S
authors.initials: S
authors.lastname: Culine
authors.forename: P
authors.initials: P
authors.lastname: Sèbe
authors.forename: M
authors.initials: M
authors.lastname: Soulié
authors.forename: J
authors.initials: J
authors.lastname: Rigaud
mesh_terms: D006801:Humans; D012186:Retroperitoneal Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D012509:Sarcoma / Q000175:diagnosis* / Q000628:therapy*